Our automated scheduling system is available 24/7. Order your test online and receive your donor/registration pass by email. Click Here
Same Day Service
At our 33 locations in the Luzerne, Pennsylvania region, Accredited Drug Testing delivers a wide array of drug and alcohol testing services. We cater to DOT and non-DOT requirements including urine and breath tests, EtG alcohol assessments, and hair drug analyses, serving individuals, businesses, and legal purposes. Quick result capabilities are offered in Luzerne, PA, with both rapid testing and SAMSA certified lab analysis. Services are available same day, with most testing sites conveniently close to your residence or workplace. We also provide Occupational Health Testing, Clinical Testing, and Background Screening.
To arrange a test, call (800) 221-4291 or register online. Select the necessary test and pick a close testing site—whether it's for you, your employees, or someone else. Our testing program is designed for convenience and speed, allowing you to book with our scheduling team or online at any time, 24/7. The streamlined process ensures scheduling drug tests near Luzerne with minimal hassle.
* You must register by phone or online to receive your donor pass/registration prior to proceeding to the testing center. You must bring a valid government issued ID along with the registration/barcode number which was sent to you by email.
When you're searching for drug testing near me or drug testing locations, we provide a simple and convenient process to find a drug and alcohol testing location near you that is certified to provide all of your drug and alcohol testing needs.
At our Luzerne drug testing collection sites, Accredited Drug Testing provides one of the widest selections of drug and alcohol testing services available. Whether you're an employer, attorney, court, or private individual, we offer both DOT and non-DOT testing options—ranging from rapid tests to comprehensive lab-based screenings—capable of detecting nearly any substance.
DOT Drug Testing and Requirements
DOT Employer Drug Policy Development
If you're an employer needing to test 25 or more employees and looking to save time and money, we offer mobile on-site drug testing where we come to you. Call us today for more information.
Luzerne County reported over 150 opioid-related overdose deaths in 2020, showcasing a significant challenge for the region.
In 2021, Luzerne County's drug treatment admissions were primarily for heroin and prescription opioids.
Luzerne, PA saw a notable increase in methamphetamine seizures by law enforcement in 2022.
Luzerne County Juvenile Probation Services reported 30% of cases involving drug use in 2021.
The rate of emergency room visits for drug-related incidents in Luzerne County increased by 25% in 2021.
Naloxone was administered over 1200 times by first responders in Luzerne County in 2020.
Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.
Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.
A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.
Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.
Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.
Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.
Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.
Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.
The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.
Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.
Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.
Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.
Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears
Employers in Luzerne, PA, are increasingly adopting stringent drug testing policies to create safer workplaces. Routine screenings are common practice in industries prone to higher incidences of drug use. For further guidance, employers often refer to resources provided by the U.S. Department of Labor and the Pennsylvania Department of Labor and Industry.
Some companies in Luzerne offer Employee Assistance Programs (EAPs) designed to support employees facing substance abuse issues, providing confidential counseling and resources. This proactive approach aids in early intervention and fosters a supportive work environment, ultimately aiming to mitigate the negative impacts of drug abuse.
The government of Luzerne County has ramped up efforts to combat drug abuse through initiatives like increased funding for rehabilitation centers and community outreach programs. These local efforts are complemented by state-level resources from the Pennsylvania Opioid Epidemic Response, which provide valuable support for recovery and prevention.
The implementation of drug courts in Luzerne County offers a tailored judicial approach to individuals with substance abuse issues, aiming to reduce recidivism by providing treatment options. Collaboration with federal agencies such as the DEA in Pennsylvania helps combat drug trafficking and distribution networks affecting the region.
Luzerne County law enforcement recently conducted a significant drug bust, seizing over 5 kg of heroin and arresting multiple individuals involved in trafficking. Coordinated efforts with state police contributed to the successful operation, reflecting ongoing vigilance against drug crimes in the area.
Recent community events in Luzerne, such as drug take-back initiatives, have shown positive engagement from residents. These programs help safely dispose of unused medications, reducing the risk of drug misuse and raising awareness about the dangers associated with prescription drug abuse.
In a collaboration with neighboring counties, Luzerne participated in a drug safety awareness event, educating the public about the signs of drug abuse. This initiative, along with workshops on healthy lifestyle choices, contributes to comprehensive prevention strategies.
Accredited Drug Testing offers fast, reliable employment screening services in Luzerne, PA. Trusted by employers nationwide for accurate results and exceptional service.
Pennsylvania DOT/Non DOT Physicals
Pennsylvania o-drug Epidemic Response
DEA Pennsylvania
U.S. Department of Labor
Pennsylvania Department of Labor and Industry
Community Services for Children, Adolescents and Adults
Caron Treatment Centers
Governor Tom Wolf's o-drug Disaster Declaration
Alcoholics Anonymous
Nar-Anon
Pennsylvania Department of Drug and Alcohol Programs
Quickly find trusted local drug testing centers in Luzerne, PA — fast, convenient, and reliable every time!
Quickly find a local DOT drug testing center in Luzerne, PA — fast, reliable, convenient nationwide service!
DNA testing for legal and non-legal purposes including child support, and child custody around Luzerne, PA.
Including specimen collector training, DER training, reasonable suspicion training and much more in Luzerne, PA.v
Get fast, accurate hair drug testing at our convenient Luzerne, PA locations—results you can trust, every time!
Fast, reliable alcohol testing to keep your workplace safe and compliant every single day in Luzerne, PA.
Reliable nationwide drug testing services ensuring accuracy, compliance, and quick results for businesses and individuals in Luzerne, PA.
Accurate 5 panel drug testing with fast, confidential results—trusted by Luzerne, PA employers and individuals nationwide.
Comprehensive 10 panel drug testing with fast, reliable results—trusted for Luzerne, PA workplace and personal testing needs.
Convenient on-site mobile drug testing with fast, reliable results—saving time while keeping your Luzerne, PA workplace compliant.
Certified DOT physicals with quick, reliable exams to keep Luzerne, PA drivers compliant and on the road with confidence.
Join our DOT consortium for hassle-free compliance, random testing management, and reliable driver safety solutions.
Trish last week and Tatiana this week, very fun and easy folks to deal with. Well be using them more and more in the future.
Tom O - 12/19/2024
Trish was amazing and got me through the sytem very fast and swift. I had a hard time hearing her a couple of times, but she was super sweet and helpful throughout the process. Highly recommend her!
Sophia Schutze - 6/19/2024
I've had to use this service twice for out of state physicians we've hired and both times it was super easy. Both customer service reps I spoke with were super helpful and courteous. I won't hesitate to use their service again if needed.
Alicia Rau - 6/19/2024